Surgery News and Research

RSS

Presbia's Flexivue lens obtains CE certification

Presbia, a leader in the development and marketing of a surgical solution for presbyopia, today announced its Flexivue™ micro-lens received CE certification for its products sold within the European Economic Area (EEA). Specifically, the CE mark certifies that Flexivue™ has met European Union consumer safety, health and environmental requirements.

4 Dec 2009

Geisinger Medical Center opens new ‘Vestibular and Balance Center’

Geisinger Medical Center recently opened a new Otolaryngology Head and Neck Surgery - Vestibular and Balance Center to help patients who are affected by vertigo, dizziness or balance problems.

4 Dec 2009

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.

3 Dec 2009

iCo Therapeutics to present an overview of its iCo-007 VEGF "+" agent at the ISOPT conference

iCo Therapeutics Inc. is pleased to announce that an overview of iCo-007, entitled "iCo-007 a VEGF "+" Agent for the Potential Treatment of Diabetic Macular Edema and Diabetic Retinopathy" will be presented at the 8th International Symposium on Ocular Pharmacology and Therapeutics ("ISOPT"), a major international ocular conference.

3 Dec 2009

Doctors' groups break ranks to oppose Senate health overhaul

The California Medical Association - which represents more than 35,000 doctors - will announce its opposition to the Senate version of the health overhaul bill later this week, the Los Angeles Times reports. The group's leaders voted to oppose the bill last week, joining several other states, including Florida and Texas.

3 Dec 2009

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

Spectranetics Corporation today announced it has received Food and Drug Administration (FDA) 510(k) clearance for its new VisiSheathTM Dilator Sheath device. This expands the market for VisiSheath, which recently also received CE Mark approval in Europe.

3 Dec 2009

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.

3 Dec 2009

PEG polymer may prevent GI injury during cancer radiotherapy

A non-absorbed, oral co-polymer therapy under development by Midway Pharmaceuticals demonstrated the ability to protect against damage to healthy gastrointestinal tissues and to prevent lethal bacterial infections in animal models of radiation damage.

3 Dec 2009

Interactive video presentation on corset trunkplasty surgery

Alexander P. Moya, M.D., Director of the Center for Weight Loss Body Contouring and Assistant Director of the Geisinger Center for Aesthetics and Cosmetic Surgery at Geisinger Medical Center (GMC), will deliver an interactive video presentation on his corset trunkplasty surgery in April 2010. This presentation will be made to a group of board-certified plastic surgeons at the American Society for Aesthetic Plastic Surgery's annual Aesthetic Meeting in Washington, D.C.

3 Dec 2009

Association of Surgeons in Training affliates with International Journal of Surgery

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that the Association of Surgeons in Training (ASiT) has affiliated with the International Journal of Surgery (IJS), an online-only peer-reviewed journal dedicated to the advancement of the science and practice of surgery.

3 Dec 2009

LSI collaborates with United Healthcare to meet the growing demand for spinal procedures

Laser Spine Institute (LSI), the leader in minimally invasive spinal surgery, is pleased to announce a partnership with United Healthcare and affiliates after an extensive six-month negotiation and clinical review process.

3 Dec 2009

CT imaging after chemotherapy with bevacizumab may help predict overall survival

Preliminary research suggests that criteria based on computed tomography (CT) imaging of changes in tumors from colorectal liver metastases after chemotherapy with the drug bevacizumab may have the potential to predict overall survival, according to a study in the December 2 issue of JAMA.

3 Dec 2009

Brandeis University researchers appraises economic benefits of BOS-P lens

Today, in the December issue of the American Journal of Ophthalmology Brandeis University researchers published a paper appraising the economic benefits of the BOS-P, a highly precise scleral lens used to treat severe cornea or ocular surface disease. A companion paper on the clinical benefits has been published online and will appear in the journal's January issue.

3 Dec 2009

Beta blockers and stress tests before non-cardiac surgeries should be avoided, according to study

Physicians should "throttle back" from routinely ordering stress tests and prescribing beta blockers to patients before non-cardiac surgeries, according to a report by the University of Michigan released online this week.

3 Dec 2009

Earlier diagnosis of cancer saves 5,000 to 10,000 lives each year, says Professor Mike Richards

Earlier diagnosis of people with cancer could save between 5,000 and 10,000 lives each year, Professor Mike Richards, the National Cancer Director for England, has claimed.

3 Dec 2009

Research finds change in the outlook of people with type 2 diabetes and heart disease

The outlook for individuals with type 2 diabetes and coronary artery disease is not as grim as originally believed, according to new Saint Louis University research published in Circulation, the Journal of the American Heart Association.

2 Dec 2009

Researchers discover ability of stem cells in brain cancer glioma to resist radiation therapy

Duke University Medical Center researchers have figured out how stem cells in the malignant brain cancer glioma may be better able to resist radiation therapy. And using a drug to block a particular signaling pathway in these cancer stem cells, they were able to kill many more glioma cells with radiation in a laboratory experiment.

2 Dec 2009

Clinical groups discuss the usage of EAS in adults and children

Electric acoustic stimulation (EAS) combines electric stimulation in the mid- to high-frequency regions with acoustic stimulation in the low-frequency range with the aim to preserve residual low-frequency hearing after cochlear implantation, which together particularly improves speech understanding, pitch discrimination and music appreciation.

2 Dec 2009

Study on the genetics of osteoarthritis

Interleukin Genetics, Inc. and NYU Langone Medical Center announced findings from a study performed in collaboration with Duke University on the genetics of osteoarthritis have been published this week in the "Online First" version of the Annals of Rheumatic Diseases and is available at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf.

2 Dec 2009

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.

2 Dec 2009

Surgery News and Research

Presbia's Flexivue lens obtains CE certification

Geisinger Medical Center opens new ‘Vestibular and Balance Center’

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

iCo Therapeutics to present an overview of its iCo-007 VEGF "+" agent at the ISOPT conference

Doctors' groups break ranks to oppose Senate health overhaul

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

PEG polymer may prevent GI injury during cancer radiotherapy

Interactive video presentation on corset trunkplasty surgery

Association of Surgeons in Training affliates with International Journal of Surgery

LSI collaborates with United Healthcare to meet the growing demand for spinal procedures

CT imaging after chemotherapy with bevacizumab may help predict overall survival

Brandeis University researchers appraises economic benefits of BOS-P lens

Beta blockers and stress tests before non-cardiac surgeries should be avoided, according to study

Earlier diagnosis of cancer saves 5,000 to 10,000 lives each year, says Professor Mike Richards

Research finds change in the outlook of people with type 2 diabetes and heart disease

Researchers discover ability of stem cells in brain cancer glioma to resist radiation therapy

Clinical groups discuss the usage of EAS in adults and children

Study on the genetics of osteoarthritis

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News